Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Diurnal lamotrigine plasma level fluctuations: clinical significance and indication of shorter half-life with chronic administration.

Nielsen KA, Dahl M, Tømmerup E, Hansen Bá, Erdal J, Wolf P.

Epilepsy Behav. 2008 Oct;13(3):470-3. doi: 10.1016/j.yebeh.2008.06.010. Epub 2008 Jul 18.

PMID:
18611447
2.
3.

Steady-state pharmacokinetics of lamotrigine when converting from a twice-daily immediate-release to a once-daily extended-release formulation in subjects with epilepsy (The COMPASS Study).

Tompson DJ, Ali I, Oliver-Willwong R, Job S, Zhu L, Lemme F, Hammer AE, Vuong A, Messenheimer JA.

Epilepsia. 2008 Mar;49(3):410-7. Epub 2007 Sep 6.

5.

Pharmacokinetic interactions between lamotrigine and other antiepileptic drugs in children with intractable epilepsy.

Eriksson AS, Hoppu K, Nergårdh A, Boreus L.

Epilepsia. 1996 Aug;37(8):769-73.

PMID:
8764817
6.

Serum concentrations of lamotrigine in epileptic patients: the influence of dose and comedication.

May TW, Rambeck B, Jürgens U.

Ther Drug Monit. 1996 Oct;18(5):523-31.

PMID:
8885114
7.

Seizure frequency in pregnant women treated with lamotrigine monotherapy.

Sabers A, Petrenaite V.

Epilepsia. 2009 Sep;50(9):2163-6. doi: 10.1111/j.1528-1167.2009.02166.x. Epub 2009 Jun 1.

8.

Influence of concomitant antiepileptic drugs on plasma lamotrigine concentration in adult Japanese epilepsy patients.

Yamamoto Y, Inoue Y, Matsuda K, Takahashi Y, Kagawa Y.

Biol Pharm Bull. 2012;35(4):487-93.

9.

Effects of various antiepileptic drugs on plasma levels of lamotrigine, a novel antiepileptic, in rats.

Yamashita S, Furuno K, Moriyama M, Kawasaki H, Gomita Y.

Pharmacology. 1997 Jun;54(6):319-27.

PMID:
9286816
10.

Tolerability and pharmacokinetics of oral loading with lamotrigine in epilepsy monitoring units.

Lardizabal DV, Morris HH, Hovinga CA, Del Mar Carreño M.

Epilepsia. 2003 Apr;44(4):536-9.

11.

Lamotrigine plasma levels reduced by oral contraceptives.

Sabers A, Buchholt JM, Uldall P, Hansen EL.

Epilepsy Res. 2001 Nov;47(1-2):151-4.

PMID:
11673029
12.

Lamotrigine plasma concentrations in children and adults: influence of age and associated therapy.

Battino D, Croci D, Granata T, Estienne M, Pisani F, Avanzini G.

Ther Drug Monit. 1997 Dec;19(6):620-7.

PMID:
9421101
13.

Variation in lamotrigine plasma concentrations with hormonal contraceptive monthly cycles in patients with epilepsy.

Contin M, Albani F, Ambrosetto G, Avoni P, Bisulli F, Riva R, Tinuper P, Baruzzi A.

Epilepsia. 2006 Sep;47(9):1573-5.

14.

Lamotrigine serum concentration-to-dose ratio: influence of age and concomitant antiepileptic drugs and dosage implications.

Armijo JA, Bravo J, Cuadrado A, Herranz JL.

Ther Drug Monit. 1999 Apr;21(2):182-90.

PMID:
10217338
15.

Pharmacokinetic interaction between retigabine and lamotrigine in healthy subjects.

Hermann R, Knebel NG, Niebch G, Richards L, Borlak J, Locher M.

Eur J Clin Pharmacol. 2003 Apr;58(12):795-802. Epub 2003 Feb 28.

PMID:
12698305
16.

Correlating lamotrigine serum concentrations with tolerability in patients with epilepsy.

Hirsch LJ, Weintraub D, Du Y, Buchsbaum R, Spencer HT, Hager M, Straka T, Bazil CW, Adams DJ, Resor SR Jr, Morrell MJ.

Neurology. 2004 Sep 28;63(6):1022-6. Review.

PMID:
15452293
17.

Lamotrigine: single-dose pharmacokinetics and initial 1 week experience in refractory epilepsy.

Jawad S, Yuen WC, Peck AW, Hamilton MJ, Oxley JR, Richens A.

Epilepsy Res. 1987 May;1(3):194-201.

PMID:
3504397
18.

A dosing algorithm for converting from valproate monotherapy to lamotrigine monotherapy in patients with epilepsy.

Sale ME, Natarajan S, Biton V, Vuong A, Hammer AE, Messenheimer JA, Blum D.

Epilepsy Behav. 2005 Feb;6(1):63-70.

PMID:
15652736
19.

Pharmacokinetics of lamotrigine (Lamictal) in plasma and saliva.

Trnavska Z, Krejcova H, Tkaczykovam, Salcmanova Z, Elis J.

Eur J Drug Metab Pharmacokinet. 1991;Spec No 3:211-5.

PMID:
1820881
20.

Supplemental Content

Support Center